Cardio Diagnostics Secures Atlas Coverage for Epi+Gen CHD and PrecisionCHD in LA
CDIO•Atlas Healthcare Physicians will cover Cardio Diagnostics’ Epi+Gen CHD and PrecisionCHD blood tests for eligible members across Los Angeles and Orange counties with prior authorization. Both noninvasive, non-fasting tests evaluate three-year risk of coronary heart disease and identify underlying molecular drivers to support personalized treatment planning within community healthcare networks.
1. Coverage Expansion with Atlas Healthcare Physicians
Cardio Diagnostics has partnered with Atlas Healthcare Physicians, an independent physician association serving managed care populations in Los Angeles and Orange counties, to secure coverage for its Epi+Gen CHD and PrecisionCHD tests. Eligible members can access these blood-based diagnostics subject to prior authorization, broadening the availability of physician-ordered cardiovascular assessments across community healthcare networks.
2. Test Details and Clinical Impact
Epi+Gen CHD quantifies a patient’s three-year risk of experiencing a coronary heart disease event, while PrecisionCHD diagnoses existing coronary disease and uncovers its molecular drivers. Both tests are noninvasive, require no fasting or radiation exposure, and leverage AI-driven genetic-epigenetic analysis to inform risk stratification and personalized treatment planning.
